Form 4: Bicycle Therapeutics Chief Accounting Officer Sells Shares for Tax Obligations

Bicycle Therapeutics PLC's Chief Accounting Officer, Travis Alvin Thompson, sold a total of 306 ordinary shares in non-discretionary transactions to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Travis Alvin Thompson, Chief Accounting Officer of Bicycle Therapeutics PLC, engaged in two non-discretionary sales of ordinary shares.
• On July 2, 2025, 206 ordinary shares were sold at a weighted average price of $7.09 per share.
• On July 3, 2025, an additional 100 ordinary shares were sold at a weighted average price of $7.44 per share.
• These sales were executed to satisfy statutory tax withholding obligations associated with the vesting and settlement of restricted stock units, as mandated by the reporting person's award agreement.
• Following these transactions, Travis Alvin Thompson beneficially owns 31,521 ordinary shares.

Sentiment

Score: 5

Explanation: The transaction is neutral as it is a non-discretionary 'sell to cover' for tax purposes, not indicative of management's sentiment on the company's prospects.

Positives

• The transactions are related to the vesting and settlement of restricted stock units, indicating that equity compensation was granted and vested.
• The sales were non-discretionary, meaning they were not a reflection of the officer's view on the company's future performance but rather a mandatory tax obligation.

Negatives

• A reduction in the direct beneficial ownership of ordinary shares by a key officer, although for a non-discretionary reason.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of an insider transaction, specifically a "sell to cover" for tax purposes. It does not provide insights into broader industry trends or competitive landscape. Such transactions are common across all industries when employees receive equity compensation.

Comparison to Industry Standards

• This is a standard "sell to cover" transaction, which is a common practice for executives and employees to meet tax obligations upon the vesting of restricted stock units.
• It aligns with typical corporate compensation and tax compliance procedures observed across publicly traded companies globally. No specific comparable companies or projects are relevant for this type of individual transaction.

Stakeholder Impact

• Shareholders: Minimal direct impact as the sale is non-discretionary and for tax purposes, not a signal of lack of confidence. The number of shares sold is relatively small compared to the total outstanding shares.
• Employees: The vesting of restricted stock units and subsequent "sell to cover" is a standard part of equity compensation plans, which can be a positive for employee retention and alignment of interests.

Key Dates

Keywords

Bicycle Therapeutics PLC, BCYC, Form 4, SEC filing, insider trading, stock sale, Chief Accounting Officer, Travis Alvin Thompson, restricted stock units, tax withholding, equity compensation